canadian consensus guidelines for the optimal use of maraviroc in the treatment of hiv-infected adults
Clicks: 212
ID: 151595
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
212 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #33 of 94 articles by views in zdravstveno varstvo
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND AND OBJECTIVES: A Canadian group, consisting of six physicians and an HIV researcher with significant experience and knowledge in HIV management, reviewed the available data and developed guidelines for Canadian health care providers (who treat HIV infection) on the appropriate use of maraviroc (UK-427,857) in HIV-infected adults.
| Reference Key |
rachlis2010canadiancanadian
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Anita Rachlis;Marianne Harris;Richard Lalonde;Stephen D Shafran;Cécile Tremblay;Mark A Wainberg;Sharon Walmsley |
| Journal | zdravstveno varstvo |
| Year | 2010 |
| DOI |
10.1155/2010/303474
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.